Literature DB >> 26713672

Severe Tumor Lysis Syndrome and Acute Pulmonary Edema Requiring Extracorporeal Membrane Oxygenation Following Initiation of Chemotherapy for Metastatic Alveolar Rhabdomyosarcoma.

Ethan Sanford1,2, Traci Wolbrink3, Jennifer Mack4, R Grant Rowe4.   

Abstract

We present an 8-year-old male with metastatic alveolar rhabdomyosarcoma (ARMS) who developed precipitous cardiopulmonary collapse with severe tumor lysis syndrome (TLS) 48 hr after initiation of chemotherapy. Despite no detectable pulmonary metastases, acute hypoxemic respiratory failure developed, requiring extracorporeal membrane oxygenation (ECMO). Although TLS has been reported in disseminated ARMS, this singular case of life-threatening respiratory deterioration developing after initiation of chemotherapy presented unique therapeutic dilemmas. We review the clinical aspects of this case, including possible mechanisms of respiratory failure, and discuss the role of ECMO utilization in pediatric oncology.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  ECMO; alveolar rhabdomyosarcoma; pediatric cancer; tumor lysis syndrome

Mesh:

Year:  2015        PMID: 26713672      PMCID: PMC5849391          DOI: 10.1002/pbc.25879

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  17 in total

Review 1.  The evolution of patient selection criteria and indications for extracorporeal life support in pediatric cardiopulmonary failure: next time, let's not eat the bones.

Authors:  Joseph R Custer
Journal:  Organogenesis       Date:  2011-01-01       Impact factor: 2.500

2.  Extracorporeal membrane oxygenation for support of children after hematopoietic stem cell transplantation: the Extracorporeal Life Support Organization experience.

Authors:  Kenneth W Gow; Mark L Wulkan; Kurt F Heiss; Ann E Haight; Micheal L Heard; Peter Rycus; James D Fortenberry
Journal:  J Pediatr Surg       Date:  2006-04       Impact factor: 2.545

3.  Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group.

Authors:  David A Rodeberg; Norbert Garcia-Henriquez; Elizabeth R Lyden; Elai Davicioni; David M Parham; Stephen X Skapek; Andrea A Hayes-Jordan; Sarah S Donaldson; Kenneth L Brown; Timothy J Triche; William H Meyer; Douglas S Hawkins
Journal:  J Clin Oncol       Date:  2011-02-28       Impact factor: 44.544

4.  Extracorporeal membrane oxygenation for nonneonatal acute respiratory failure.

Authors:  P T Masiakos; S Islam; D P Doody; J J Schnitzer; D P Ryan
Journal:  Arch Surg       Date:  1999-04

5.  Extracorporeal membrane oxygenation after stem cell transplant: clinical decision-making in the absence of evidence.

Authors:  Rachel K Wolfson; Madelyn D Kahana; James B Nachman; John Lantos
Journal:  Pediatr Crit Care Med       Date:  2005-03       Impact factor: 3.624

6.  Extracorporeal life support for adults with malignancy and respiratory or cardiac failure: The Extracorporeal Life Support experience.

Authors:  Kenneth W Gow; Oliver B Lao; Traci Leong; James D Fortenberry
Journal:  Am J Surg       Date:  2010-05       Impact factor: 2.565

Review 7.  What is new in the biology and treatment of pediatric rhabdomyosarcoma?

Authors:  Douglas S Hawkins; Abha A Gupta; Erin R Rudzinski
Journal:  Curr Opin Pediatr       Date:  2014-02       Impact factor: 2.856

Review 8.  Childhood rhabdomyosarcoma metastatic to bone marrow presenting with disseminated intravascular coagulation and acute tumour lysis syndrome: review of the literature apropos of two cases.

Authors:  Ewa Bien; Lucyna Maciejka-Kapuscinska; Maciej Niedzwiecki; Joanna Stefanowicz; Anna Szolkiewicz; Malgorzata Krawczyk; Jadwiga Maldyk; Ewa Izycka-Swieszewska; Beata Tokarska; Anna Balcerska
Journal:  Clin Exp Metastasis       Date:  2010-06-02       Impact factor: 5.150

9.  Extracorporeal life support for severe respiratory failure in children with immune compromised conditions.

Authors:  Monika Gupta; Thomas P Shanley; Frank W Moler
Journal:  Pediatr Crit Care Med       Date:  2008-07       Impact factor: 3.624

10.  Extracorporeal life support for support of children with malignancy and respiratory or cardiac failure: The extracorporeal life support experience.

Authors:  Kenneth W Gow; Kurt F Heiss; Mark L Wulkan; Howard M Katzenstein; Eli S Rosenberg; Michael L Heard; Peter T Rycus; James D Fortenberry
Journal:  Crit Care Med       Date:  2009-04       Impact factor: 7.598

View more
  3 in total

1.  Continuous infusion chemotherapy, radiotherapy, and FDG-PET are feasible during extracorporeal membrane oxygenation.

Authors:  Seth J Rotz; Francisco A Almeida; Shlomo Koyfman; Sudhir Krishnan; Guramrinder Singh Thind; William Phillips; James Yun; Anthony Zembillas; Mark Zahniser; Alejandro Bribriesco
Journal:  Pediatr Blood Cancer       Date:  2020-07-16       Impact factor: 3.167

2.  Rituximab Induced Pulmonary Edema Managed with Extracorporeal Life Support.

Authors:  Jacob R Miller; Warren Isakow; Muhammad F Masood; Patrick Aguilar; Kristen M Sanfilippo; Keki R Balsara; Akinobu Itoh
Journal:  Case Rep Crit Care       Date:  2018-01-17

3.  Successful Use of Extracorporeal Life Support and Continuous Renal Replacement Therapy in the Treatment of Cardiogenic Shock Induced by Tumor Lysis Syndrome in a Pediatric Patient With Lymphoma: A Case Report.

Authors:  Zhulin Wang; Fang Zhang; Long Xiang; Yinyu Yang; Wei Wang; Biru Li; Hong Ren
Journal:  Front Med (Lausanne)       Date:  2022-01-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.